Business Description
NetraMark Holdings Inc. is a Toronto-based company founded in 2016 that builds AI software for the healthcare and life sciences industry. Its core product is the NetraAI platform, which uses machine learning to help drug developers and research organizations make better sense of clinical trial data. The platform is particularly useful for spotting distinct patient groups within trial populations, which can lead to more targeted and effective treatments.
